With this approach, autologous or allogenic CD8 T cells transduced with tumor antigen-specific TCRs (CD8 TCR-T cells) or chimeric antigen receptors (CAR-T cells) are cultured in vitro and then adoptively transferred into patients (20). The gene discussed is CD8A; the disease is neoplasm.